ClinicalTrials.Veeva

Menu

Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population (PARKA)

U

Université de Sherbrooke

Status

Active, not recruiting

Conditions

Alzheimer Disease
Parkinson Disease

Treatments

Dietary Supplement: Betaquik MCT supplement

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04322461
2020-3436

Details and patient eligibility

About

A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.

Enrollment

14 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Alzheimer's or parkinson disease diagnostic
  • Stable medication associated with the disease
  • Able to consent
  • Presence of an accompanying person for the first and last visit.
  • Ability to read and talk in French

Exclusion criteria

  • MMSE < 20
  • MCT or coconut oil supplementation
  • Coconut allergy
  • Cannabis, THC or CBD consumption
  • Excessive alcohol consumption
  • Physical activity 3x/week
  • Presence of an metallic object in the body
  • Impossibility to lay in dorsal decubitus for 40 minutes
  • Cardiac disease
  • Any uncontrolled disease that could interfer with the project.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

14 participants in 2 patient groups

Parkinson disease
Experimental group
Description:
2 months intervention with 50g/day of a commercial MCT supplement combine with supervised aerobic exercise 3x/week.
Treatment:
Dietary Supplement: Betaquik MCT supplement
Alzheimer's disease
Experimental group
Description:
2 months intervention with 50g/day of a commercial MCT supplement combine with supervised aerobic exercise 3x/week.
Treatment:
Dietary Supplement: Betaquik MCT supplement

Trial contacts and locations

1

Loading...

Central trial contact

Mélanie Fortier, M.Sc.; Valérie St-Pierre, M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems